Danish study shows #colorectal #cancer recurrence rates have dropped from 2004 to 2019. Lower-stage cancers had longer time to recurrence and better outcomes, highlighting the need for personalized surveillance. Aarhus Uni.hospital Claus Lindbjerg Andersen Jesper Nors buff.ly/490khfI

📢 New reporting guideline for consensus methods in health research: ACCORD 📝 Learn how to report your consensus studies with clarity and transparency using this 35-item checklist: buff.ly/47IJ46V #medcomms #healthresearch

WHO releases guidance on ethics and governance of large multi-modal models 👉 AI can improve healthcare but also pose risks of false or biased information 👉 WHO outlines recommendations to ensure appropriate use of AI in healthcare Read more: buff.ly/3vP1BBc #AI #WHO

Today is #WorldCancerDay Here are some ways to reduce your cancer risk: 🚭 Don’t use tobacco 🏃 Exercise regularly  🍏 Eat more fruits and vegetables  ✅ Maintain a healthy weight  🍷 Limit alcohol consumption  Let's beat cancer!  🔗 bit.ly/3OpoUZ1 #WorldCancerDay

How many cancer survivors are there in Europe? 👉 A new study estimates cancer prevalence for 29 countries and 32 cancer types in 2020 👉 Find out the trends and implications for health policies and survivorship care 🔗 Full article: buff.ly/3Sw56UO #cancer #oncology

👉 R21/Matrix-M vaccine showed >70% efficacy against clinical malaria in children aged 5-36 months in Africa 🌍 👉 Low-cost, high-efficacy vaccine could save millions of lives 👉 Read the full article here: buff.ly/3w8ErpP #Malaria #vaccine #GlobalHealth #medtwitter

Can we use AI to diagnose melanoma without sharing patient data? A new study shows that federated learning can achieve comparable performance to centralized approaches while preserving patient privacy. 🔗 Read the study: buff.ly/3Uwulci #melanoma #AI #federatedlearning

1/ The long-awaited OS results from #KEYNOTE-564 are out NEJM! The 1st phase 3 trial to demonstrate a survival benefit for adjuvant treatment in #RCC. nejm.org/doi/full/10.10…

In the last 50 years, #immunization has decreased infant mortality by 40%. That means more children now reach their 5th birthday than ever before in human history. Celebrate and protect this incredible achievement. Fund immunization for all. A healthier world is

Pharaoh Ramses V comes to life. Watch this fascinating story about the eradication of a deadly disease. #SMALLPOX! Did you know? Following an ambitious 12-year global vaccination campaign led by the WHO, smallpox was finally eradicated in 1980. 🙌 #WorldImmunizationWeek

Kevin Piette, paraplegic since an accident, made history today by carrying the Olympic flame with his exoskeleton! 💪

Today is #SelfCare Day! Self-care helps people 🛡️ Protect their health 💪🏼 Prevent disease 🩹 Manage illness & disability 🆕 WHO guidance to help countries integrate self-care within health care bit.ly/4dxmD8n

It's World #Hepatitis Day. Here is how you can take action to protect yourself and your loved ones: 🔹 Get tested 🔹 Never share sharp instruments 🔹 Get treated 🔹 Vaccinate babies within 24 hours of birth bit.ly/3YijTXN

🔥off the press: ESMO Open Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer 👏Great consensus with our Asian friends & colleagues 👇my personal link to share: authors.elsevier.com/sd/article/S20… ESMO - Eur. Oncology

𝐎𝐩𝐞𝐧𝐂𝐑𝐈𝐒𝐏𝐑-1: 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐀𝐈 𝐌𝐞𝐞𝐭𝐬 𝐂𝐑𝐈𝐒𝐏𝐑 Researchers at Profluent used large language models to expand the sequence diversity of CRISPR-Cas proteins and generate novel, functional genome editors with improved properties compared to natural

Today is #WorldSuicidePreventionDay Every year, more than 700,000 people die due to suicide. Every death is a tragedy, leaving lasting effects on families & communities. But, with the right support and interventions, suicide can be prevented bit.ly/3B0bxuA

mFOLFOX plus/minus Nivo & Ipi vs FLOT + nivolumab in metastatic G/GEJ adenocarcinoma #ESMO24 🔎IKF-AIO-Moonlight trial 👉ORR 46 vs 32 vs 47 vs 56% 👉PFS: 5,8 vs 4 vs 6,6 vs 7 mo 👉mOS: 10 vs 7,6 vs 12,5 vs 14,6 mo 🧐Only FLOT + Nivo seems feasible & effective ESMO - Eur. Oncology

Neoadjuvant immunotherapy in locally advanced MMR-deficient colon cancer: #ESMO24 🔎3-year disease-free survival from NICHE-2 👉💯% DFS 👉all MRD pts cleared ctDNA 🧐Impressive results, ctDNA may be helpful to select for organ preservation ESMO - Eur. Oncology #ESMOAmbassadors

Checkmate 067 10 year data 🚨 presented by James Larkin with concurrent NEJM publication. 10 years of ipi+nivo revolutionizing melanoma care and changing the way we treat cancer!! 10y MSS is >50%! #ESMO24 OncoAlert nejm.org/doi/abs/10.105…

Perioperative durvalumab + neoadjuvant chemo & cystectomy in operable bladder cancer significantly delays (HR 0.68) event free survival and a 25% reduction in the risk of death. 10% ⬆️ pCR. It’s the 1st time immune therapy has an OS benefit in muscle invasive UC #ESM024 NEJM